Qaialdo 欧州連合 - アイスランド語 - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - spironolactone - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 5.

Orfadin 欧州連合 - アイスランド語 - EMA (European Medicines Agency)

orfadin

swedish orphan biovitrum international ab - nitisinón - tyrosinemias - Önnur meltingarvegi og efnaskipti vörur, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).

Attentin Tafla 10 mg アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

attentin tafla 10 mg

medice arzneimittel pütter gmbh & co. kg* - dexamfetaminum súlfat - tafla - 10 mg

Attentin Tafla 20 mg アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

attentin tafla 20 mg

medice arzneimittel pütter gmbh & co. kg* - dexamfetaminum súlfat - tafla - 20 mg

Attentin Tafla 5 mg アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

attentin tafla 5 mg

medice arzneimittel pütter gmbh & co. kg* - dexamfetaminum súlfat - tafla - 5 mg